Charles Schwab’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-980,711
Closed -$15.1M 3475
2025
Q4
$15.1M Buy
980,711
+92,178
+10% +$1.02M ﹤0.01% 1927
2025
Q3
$8.82M Sell
888,533
-109,702
-11% -$1.14M ﹤0.01% 2166
2025
Q2
$9.9M Sell
998,235
-159,758
-14% -$1.68M ﹤0.01% 2022
2025
Q1
$15M Buy
1,157,993
+2,913
+0.3% +$38.5K ﹤0.01% 1769
2024
Q4
$14.8M Buy
1,155,080
+32,347
+3% +$391K ﹤0.01% 1844
2024
Q3
$12.5M Sell
1,122,733
-14,840
-1% -$164K ﹤0.01% 1926
2024
Q2
$12.8M Buy
1,137,573
+58,702
+5% +$683K ﹤0.01% 1917
2024
Q1
$13.4M Buy
1,078,871
+14,869
+1% +$194K ﹤0.01% 1835
2023
Q4
$14.9M Sell
1,064,002
-17,787
-2% -$247K ﹤0.01% 1775
2023
Q3
$16M Buy
1,081,789
+95,690
+10% +$1.35M ﹤0.01% 1639
2023
Q2
$12.7M Buy
986,099
+44,895
+5% +$512K ﹤0.01% 1793
2023
Q1
$9.23M Buy
941,204
+3,321
+0.4% +$35.5K ﹤0.01% 1914
2022
Q4
$9.98M Buy
937,883
+5,941
+0.6% +$69K ﹤0.01% 1857
2022
Q3
$9.73M Sell
931,942
-278
-0% -$3.62K ﹤0.01% 1850
2022
Q2
$11.7M Buy
932,220
+25,244
+3% +$268K ﹤0.01% 1748
2022
Q1
$9.83M Buy
906,976
+49,650
+6% +$603K ﹤0.01% 1965
2021
Q4
$12.1M Buy
857,326
+67,923
+9% +$1.12M ﹤0.01% 1906
2021
Q3
$15.2M Buy
789,403
+129
+0% +$1.71K 0.01% 1779
2021
Q2
$7.78M Buy
789,274
+88,429
+13% +$804K ﹤0.01% 2134
2021
Q1
$6.89M Buy
700,845
+42,916
+7% +$354K ﹤0.01% 2142
2020
Q4
$2.93M Buy
657,929
+315
+0% +$1.43K ﹤0.01% 2467
2020
Q3
$2.84M Sell
657,614
-1,150
-0.2% -$8.21K ﹤0.01% 2362
2020
Q2
$5.84M Buy
658,764
+133,715
+25% +$676K ﹤0.01% 1952
2020
Q1
$1.85M Buy
525,049
+12,762
+2% +$59.2K ﹤0.01% 2301
2019
Q4
$2.93M Buy
512,287
+7,398
+1% +$39.6K ﹤0.01% 2288
2019
Q3
$1.8M Buy
504,889
+166,390
+49% +$645K ﹤0.01% 2412
2019
Q2
$1.35M Sell
338,499
-4,826
-1% -$28K ﹤0.01% 2481
2019
Q1
$2.51M Buy
343,325
+11,368
+3% +$111K ﹤0.01% 2287
2018
Q4
$3.04M Buy
331,957
+7,510
+2% +$83.1K ﹤0.01% 2160
2018
Q3
$4.02M Buy
324,447
+17,947
+6% +$243K ﹤0.01% 2169
2018
Q2
$4.67M Buy
306,500
+17,420
+6% +$301K ﹤0.01% 2037
2018
Q1
$5.74M Buy
289,080
+12,650
+5% +$218K ﹤0.01% 1865
2017
Q4
$5.17M Buy
276,430
+41,120
+17% +$826K ﹤0.01% 1903
2017
Q3
$5.06M Buy
235,310
+54,149
+30% +$857K ﹤0.01% 1876
2017
Q2
$1.75M Buy
181,161
+79,141
+78% +$514K ﹤0.01% 2262
2017
Q1
$608K Sell
102,020
-22,440
-18% -$108K ﹤0.01% 2578
2016
Q4
$492K Sell
124,460
-4,174
-3% -$30.6K ﹤0.01% 2652
2016
Q3
$1.35M Sell
128,634
-3,318
-3% -$47.7K ﹤0.01% 2307
2016
Q2
$1.92M Buy
131,952
+2,160
+2% +$36.9K ﹤0.01% 2092
2016
Q1
$2.5M Buy
129,792
+2,496
+2% +$50.4K ﹤0.01% 1933
2015
Q4
$3.08M Buy
127,296
+16,189
+15% +$406K ﹤0.01% 1835
2015
Q3
$2.73M Buy
111,107
+54,457
+96% +$1.54M ﹤0.01% 1886
2015
Q2
$1.33M Buy
56,650
+7,600
+15% +$166K ﹤0.01% 2288
2015
Q1
$1.1M Hold
49,050
﹤0.01% 2332
2014
Q4
$827K Hold
49,050
﹤0.01% 2435
2014
Q3
$702K Hold
49,050
﹤0.01% 2464
2014
Q2
$785K Hold
49,050
﹤0.01% 2434
2014
Q1
$883K Buy
49,050
+7,900
+19% +$147K ﹤0.01% 2350
2013
Q4
$807K Buy
41,150
+13,580
+49% +$199K ﹤0.01% 2371
2013
Q3
$345K Sell
27,570
-12,692
-32% -$160K ﹤0.01% 2695
2013
Q2
$431K Buy
+40,262
New +$848K ﹤0.01% 2577

Other funds holding DVAX

Charles Schwab's DVAX Position: Q1 2026 in Review

Charles Schwab sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 980,711 shares — an estimated $15.1M sold.

Charles Schwab first reported a position in DVAX in Q2 2013 and held it in 51 quarters. The position peaked at $16M in Q3 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Charles Schwab reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Charles Schwab sold 980,711 Dynavax Technologies shares in Q1 2026, an estimated $15.1M.
  • Charles Schwab first reported a position in Dynavax Technologies in Q2 2013 and held it in 51 quarters.
  • Charles Schwab's Dynavax Technologies position peaked at $16M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.